Biomarker ID | 1795 |
PMID | 30352818 |
Year | 2018 |
Biomarker | Phospholipids to total lipids ratio in medium LDL |
Biomarker Basis | Concentration Based |
Biomolecule | Metabolites |
Source | Blood |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | OR: 0.904 (95% CI: 0.853-0.957) |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs No Prostate Cancer |
Type of Biomarker | Diagnostic |
Cohort | For the study, 2291 PCa patients along with 2661 controls were selected for the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.00046 |
Method Used | Nuclear Magnetic Resonance (NMR) spectroscopy |
Clinical | Yes |
Remarks | NA |
Clinical Trial Number | ISRCTN20141297 |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |